Tags

Type your tag names separated by a space and hit enter

Preoperative weight loss by intragastric balloon in super-obese patients treated with laparoscopic gastric banding: a case-control study.
Obes Surg. 2004 May; 14(5):671-6.OS

Abstract

BACKGROUND

The authors investigated the usefulness of preoperative treatment with the BIB intragastric balloon in super-obese patients before undergoing laparoscopic adjustable gastric banding (LAGB).

METHODS

The case-control study involved 43 case patients treated with the intragastric balloon followed by LAGB ("Case" group) and 43 sex-, age- and BMI-matched historical controls treated with LAGB alone.

RESULTS

Mean length of the intragastric balloon treatment was 164.4+/-39.7 days, with a fill volume of 609+/-95 ml. Total complication rate with balloon was 7.0% and percent excess weight loss (%EWL) was 26.1 +/- SD 9.3 %. At the time of gastric band placement, both operative time and hospital stay were shorter in patients treated previously with the balloon (Case group) than in the Control group patients. No Case patients required conversion to open surgery or had intraoperative complications. In the Control group, the rate of conversion was 16.3% (P<0.05) and the rate of intraoperative complications was 7.0%. Postoperative follow-up length was 1.1+/-1.0 years in Case patients and 4.4+/-1.8 years in Control patients (P<0.001). The %EWL produced by the intragastric balloon in the Case patients was identical to the %EWL observed in the first 6 months after LAGB in the Control group (26.1+/-9.3 vs 25.3+/-12.4%). %EWL 6 months after banding was higher in the Case patients than in Controls (33.6+/-12.5 vs 25.3+/-12.4%, P<0.01). However, no significant difference in %EWL between the two groups was observed at the subsequent postoperative evaluations.

CONCLUSION

Preoperative treatment with the intragastric balloon reduced the risk of conversion to open surgery and the risk of intraoperative complications in super-obese patients treated with LAGB. Preoperative treatment with the intragastric balloon did not change the total weight loss after LAGB.

Authors+Show Affiliations

Department of Medical and Surgical Sciences, University of Padova, Padova, Italy. luca.busetto@unipd.itNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

15186637

Citation

Busetto, Luca, et al. "Preoperative Weight Loss By Intragastric Balloon in Super-obese Patients Treated With Laparoscopic Gastric Banding: a Case-control Study." Obesity Surgery, vol. 14, no. 5, 2004, pp. 671-6.
Busetto L, Segato G, De Luca M, et al. Preoperative weight loss by intragastric balloon in super-obese patients treated with laparoscopic gastric banding: a case-control study. Obes Surg. 2004;14(5):671-6.
Busetto, L., Segato, G., De Luca, M., Bortolozzi, E., MacCari, T., Magon, A., Inelmen, E. M., Favretti, F., & Enzi, G. (2004). Preoperative weight loss by intragastric balloon in super-obese patients treated with laparoscopic gastric banding: a case-control study. Obesity Surgery, 14(5), 671-6.
Busetto L, et al. Preoperative Weight Loss By Intragastric Balloon in Super-obese Patients Treated With Laparoscopic Gastric Banding: a Case-control Study. Obes Surg. 2004;14(5):671-6. PubMed PMID: 15186637.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Preoperative weight loss by intragastric balloon in super-obese patients treated with laparoscopic gastric banding: a case-control study. AU - Busetto,Luca, AU - Segato,Gianni, AU - De Luca,Maurizio, AU - Bortolozzi,Enzo, AU - MacCari,Tommaso, AU - Magon,Alessandro, AU - Inelmen,Eminé Meral, AU - Favretti,Franco, AU - Enzi,Giuliano, PY - 2004/6/10/pubmed PY - 2004/9/8/medline PY - 2004/6/10/entrez SP - 671 EP - 6 JF - Obesity surgery JO - Obes Surg VL - 14 IS - 5 N2 - BACKGROUND: The authors investigated the usefulness of preoperative treatment with the BIB intragastric balloon in super-obese patients before undergoing laparoscopic adjustable gastric banding (LAGB). METHODS: The case-control study involved 43 case patients treated with the intragastric balloon followed by LAGB ("Case" group) and 43 sex-, age- and BMI-matched historical controls treated with LAGB alone. RESULTS: Mean length of the intragastric balloon treatment was 164.4+/-39.7 days, with a fill volume of 609+/-95 ml. Total complication rate with balloon was 7.0% and percent excess weight loss (%EWL) was 26.1 +/- SD 9.3 %. At the time of gastric band placement, both operative time and hospital stay were shorter in patients treated previously with the balloon (Case group) than in the Control group patients. No Case patients required conversion to open surgery or had intraoperative complications. In the Control group, the rate of conversion was 16.3% (P<0.05) and the rate of intraoperative complications was 7.0%. Postoperative follow-up length was 1.1+/-1.0 years in Case patients and 4.4+/-1.8 years in Control patients (P<0.001). The %EWL produced by the intragastric balloon in the Case patients was identical to the %EWL observed in the first 6 months after LAGB in the Control group (26.1+/-9.3 vs 25.3+/-12.4%). %EWL 6 months after banding was higher in the Case patients than in Controls (33.6+/-12.5 vs 25.3+/-12.4%, P<0.01). However, no significant difference in %EWL between the two groups was observed at the subsequent postoperative evaluations. CONCLUSION: Preoperative treatment with the intragastric balloon reduced the risk of conversion to open surgery and the risk of intraoperative complications in super-obese patients treated with LAGB. Preoperative treatment with the intragastric balloon did not change the total weight loss after LAGB. SN - 0960-8923 UR - https://www.unboundmedicine.com/medline/citation/15186637/Preoperative_weight_loss_by_intragastric_balloon_in_super_obese_patients_treated_with_laparoscopic_gastric_banding:_a_case_control_study_ L2 - https://dx.doi.org/10.1381/096089204323093471 DB - PRIME DP - Unbound Medicine ER -